[go: up one dir, main page]

IN2013MU03646A - - Google Patents

Download PDF

Info

Publication number
IN2013MU03646A
IN2013MU03646A IN3646MU2013A IN2013MU03646A IN 2013MU03646 A IN2013MU03646 A IN 2013MU03646A IN 3646MU2013 A IN3646MU2013 A IN 3646MU2013A IN 2013MU03646 A IN2013MU03646 A IN 2013MU03646A
Authority
IN
India
Prior art keywords
acne
hydrates
stable
treatment
provides
Prior art date
Application number
Inventor
Amol Mandhare
Nilendusen
Paul B Mcgarty
Original Assignee
Lupin Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lupin Ltd filed Critical Lupin Ltd
Priority to US15/037,822 priority Critical patent/US20160287614A1/en
Priority to PCT/IB2014/066152 priority patent/WO2015075640A1/en
Priority to IN3646MU2013 priority patent/IN2013MU03646A/en
Publication of IN2013MU03646A publication Critical patent/IN2013MU03646A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/35—Ketones, e.g. benzophenone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Birds (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

The present invention provides a stable, organoleptically acceptable topical formulation(s) of the tetracycline antibiotics or pharmaceutically acceptable salts or hydrates thereof for the treatment of acne.
IN3646MU2013 2013-11-20 2014-11-19 IN2013MU03646A (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
US15/037,822 US20160287614A1 (en) 2013-11-20 2014-11-19 Stable Pharmaceutical Formulation(s) of Tetracycline Antibiotic
PCT/IB2014/066152 WO2015075640A1 (en) 2013-11-20 2014-11-19 Stable pharmaceutical formulation(s) of tetracycline antibiotic
IN3646MU2013 IN2013MU03646A (en) 2013-11-20 2014-11-19

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN3646MU2013 IN2013MU03646A (en) 2013-11-20 2014-11-19

Publications (1)

Publication Number Publication Date
IN2013MU03646A true IN2013MU03646A (en) 2015-07-31

Family

ID=52023578

Family Applications (1)

Application Number Title Priority Date Filing Date
IN3646MU2013 IN2013MU03646A (en) 2013-11-20 2014-11-19

Country Status (3)

Country Link
US (1) US20160287614A1 (en)
IN (1) IN2013MU03646A (en)
WO (1) WO2015075640A1 (en)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
US20080138296A1 (en) 2002-10-25 2008-06-12 Foamix Ltd. Foam prepared from nanoemulsions and uses
US7700076B2 (en) 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
MXPA05004278A (en) 2002-10-25 2005-10-05 Foamix Ltd Cosmetic and pharmaceutical foam.
US20080260655A1 (en) 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
US9439857B2 (en) 2007-11-30 2016-09-13 Foamix Pharmaceuticals Ltd. Foam containing benzoyl peroxide
WO2009090495A2 (en) 2007-12-07 2009-07-23 Foamix Ltd. Oil and liquid silicone foamable carriers and formulations
US20120087872A1 (en) 2009-04-28 2012-04-12 Foamix Ltd. Foamable Vehicles and Pharmaceutical Compositions Comprising Aprotic Polar Solvents and Uses Thereof
WO2011013009A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
CA2769677A1 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
WO2011039637A2 (en) 2009-10-02 2011-04-07 Foamix Ltd. Surfactant-free water-free foamable compositions, breakable foams and gels and their uses
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
CA2977612A1 (en) 2015-02-25 2016-09-01 Sun Pharma Advanced Research Company Ltd Nanoparticulate composition
MX2017012062A (en) 2015-03-23 2018-06-18 Biopharmx Inc Pharmaceutical tetracycline composition for dermatological use.
US11253614B2 (en) 2016-08-23 2022-02-22 University Of Maryland, Baltimore Methods for detecting and/or predicting age-related macular degeneration and/or Alzheimer's disease
MX2020012139A (en) 2016-09-08 2021-01-29 Vyne Pharmaceuticals Inc Compositions and methods for treating rosacea and acne.
TR201910426A2 (en) * 2019-07-12 2019-08-21 Assos Ilac Kimya Gida Ueruenleri Ueretim Ve Ticaret Anonim Sirketi STABILITY FORMULATION WITH TETRASYCLIN AND TRETINOIN FOR TOPICAL ACNE TREATMENT
CN112022809A (en) * 2020-08-14 2020-12-04 河北远征药业有限公司 A kind of oxytetracycline aerosol and preparation method thereof
CN111956612A (en) * 2020-08-14 2020-11-20 河北远征药业有限公司 Oxytetracycline spray and preparation method thereof
CN115554243B (en) * 2022-11-11 2023-03-03 新基元(北京)医药科技有限公司 Minocycline foam for treating acne rosacea

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3219529A (en) 1962-10-04 1965-11-23 American Cyanamid Co Stable tetracycline solutions
US3389174A (en) 1962-10-04 1968-06-18 American Cyanamid Co Stable tetracycline solutions
US4376118A (en) 1980-10-06 1983-03-08 Miles Laboratories, Inc. Stable nonaqueous solution of tetracycline salt
US5122519A (en) * 1989-06-27 1992-06-16 American Cyanamid Company Stable, cosmetically acceptable topical gel formulation and method of treatment for acne
US20080188445A1 (en) 2007-02-02 2008-08-07 Warner Chilcott Company Inc. Tetracycline compositions for topical administration
US20080188446A1 (en) 2007-02-02 2008-08-07 Warner Chilcott Company Inc. Tetracycline compositions for topical administration
WO2009090495A2 (en) * 2007-12-07 2009-07-23 Foamix Ltd. Oil and liquid silicone foamable carriers and formulations
PT104644B (en) 2009-06-26 2012-11-06 Hovione Farmaciencia S A Topical formulation containing a tetracycline and a method of treating skin infections using the same
US8592380B2 (en) * 2010-03-26 2013-11-26 Precision Dermatology, Inc. Aerosol foams comprising clindamycin phosphate
AU2012207203B2 (en) * 2011-01-19 2017-08-03 Laboratory Skin Care, Inc. Topical minocycline compositions and methods of using the same

Also Published As

Publication number Publication date
US20160287614A1 (en) 2016-10-06
WO2015075640A1 (en) 2015-05-28

Similar Documents

Publication Publication Date Title
IN2013MU03646A (en)
PH12019501321A1 (en) Methods of treating or preventing cholesterol related disorders
TN2015000519A1 (en) Small molecule inhibitors of fibrosis
PH12015502031B1 (en) Tetrahydropyrrolothiazine compounds
MX361499B (en) Deuterated baricitinib.
MX2015001246A (en) Deuterated ibrutinib.
HK1216083A1 (en) Trans-arterial drug delivery
EP3019166A4 (en) A pharmaceutical combination for the treatment of melanoma
PH12015501588A1 (en) Compounds and methods for treating bacterial infections
WO2014153495A3 (en) Novel stat3 inhibitors
CL2016001349A1 (en) Use of benzimidazole-proline derivatives
MX2015008829A (en) Deuterated momelotinib.
IN2013MU03862A (en)
NZ730816A (en) Quinoline carboxamides for use in the treatment of multiple myeloma
WO2014145314A3 (en) Methods and compositions for gamma-glutamyl cycle modulation
IN2013MU01985A (en)
NZ732704A (en) Quinoline carboxamides for use in the treatment of leukemia
HK1212978A1 (en) Novel derivatives of sinapinic acid
MX345263B (en) Stable pexiganan formulation.
MX2016005160A (en) Pharmaceutical compositions comprising antibacterial agents.
EP3094316A4 (en) Fullerene compounds as antioxidant therapy
EP3054996A4 (en) High purity therapeutic bone agents
MX2015012610A (en) Deuterated pacritinib.
MX2016005539A (en) Pharmaceutical compositions comprising antibacterial agents.
NZ719215A (en) Pharmaceutical compositions comprising antibacterial agents